These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24212615)

  • 21. Treatment of high-risk neuroblastoma with anti-GD2 antibodies.
    Castel V; Segura V; Cañete A
    Clin Transl Oncol; 2010 Dec; 12(12):788-93. PubMed ID: 21156409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation.
    Peng CA; Wang CH
    Cancers (Basel); 2011 Jan; 3(1):227-40. PubMed ID: 24212615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin.
    Inagaki FF; Kato T; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Choyke PL; Kobayashi H
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation.
    Charan S; Sanjiv K; Singh N; Chien FC; Chen YF; Nergui NN; Huang SH; Kuo CW; Lee TC; Chen P
    Bioconjug Chem; 2012 Nov; 23(11):2173-82. PubMed ID: 23030814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.
    Parsons K; Bernhardt B; Strickland B
    Ann Pharmacother; 2013 Feb; 47(2):210-8. PubMed ID: 23386066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro photothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody.
    Wang CH; Huang YJ; Chang CW; Hsu WM; Peng CA
    Nanotechnology; 2009 Aug; 20(31):315101. PubMed ID: 19597244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects.
    Alkilany AM; Nagaria PK; Hexel CR; Shaw TJ; Murphy CJ; Wyatt MD
    Small; 2009 Mar; 5(6):701-8. PubMed ID: 19226599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
    Pule MA; Savoldo B; Myers GD; Rossig C; Russell HV; Dotti G; Huls MH; Liu E; Gee AP; Mei Z; Yvon E; Weiss HL; Liu H; Rooney CM; Heslop HE; Brenner MK
    Nat Med; 2008 Nov; 14(11):1264-70. PubMed ID: 18978797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment.
    Di Paolo D; Pastorino F; Brignole C; Marimpietri D; Loi M; Ponzoni M; Pagnan G
    Tumori; 2008; 94(2):246-53. PubMed ID: 18564613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical sensing and imaging with metallic nanorods.
    Murphy CJ; Gole AM; Hunyadi SE; Stone JW; Sisco PN; Alkilany A; Kinard BE; Hankins P
    Chem Commun (Camb); 2008 Feb; (5):544-57. PubMed ID: 18209787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods.
    Norman RS; Stone JW; Gole A; Murphy CJ; Sabo-Attwood TL
    Nano Lett; 2008 Jan; 8(1):302-6. PubMed ID: 18062714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroblastoma.
    Maris JM; Hogarty MD; Bagatell R; Cohn SL
    Lancet; 2007 Jun; 369(9579):2106-20. PubMed ID: 17586306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disialoganglioside directed immunotherapy of neuroblastoma.
    Modak S; Cheung NK
    Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEG-modified gold nanorods with a stealth character for in vivo applications.
    Niidome T; Yamagata M; Okamoto Y; Akiyama Y; Takahashi H; Kawano T; Katayama Y; Niidome Y
    J Control Release; 2006 Sep; 114(3):343-7. PubMed ID: 16876898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of thiol-passivated gold particles at elevated temperatures studied by X-ray photoelectron spectroscopy.
    Büttner M; Belser T; Oelhafen P
    J Phys Chem B; 2005 Mar; 109(12):5464-7. PubMed ID: 16851582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation.
    Chen CC; Lin YP; Wang CW; Tzeng HC; Wu CH; Chen YC; Chen CP; Chen LC; Wu YC
    J Am Chem Soc; 2006 Mar; 128(11):3709-15. PubMed ID: 16536544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods.
    Huang X; El-Sayed IH; Qian W; El-Sayed MA
    J Am Chem Soc; 2006 Feb; 128(6):2115-20. PubMed ID: 16464114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity.
    Takahashi H; Niidome Y; Niidome T; Kaneko K; Kawasaki H; Yamada S
    Langmuir; 2006 Jan; 22(1):2-5. PubMed ID: 16378388
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.